Screening for pancreatic cancer: a review for general clinicians

Wiest, Nathaniel E.; Moktan, Varun P.; Oman, Sven P.; Chirilă, Răzvan M.

Screening for pancreatic cancer: a review for general clinicians

Romanian Journal of Internal Medicine

Volume 58 (2020): Issue 3 (September 2020)

By:

Nathaniel E. Wiest, Varun P. Moktan, Sven P. Oman and Răzvan M. Chirilă

Open Access

|Aug 2020

References

1. SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM. Cancer Stat Facts: Pancreatic Cancer. 2019. Accessed from <www.seer.cancer.gov> on 11/30/2019.
Search in Google Scholar Back to article
2. MCGUIGAN A., KELLY P., TURKINGTON, RC., JONES C., COLEMAN HG., MCCAIN RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43):4846–4861.10.3748/wjg.v24.i43.4846625092430487695
Search in Google Scholar Back to article
3. MORRISON AH., BRYNE KT., VONDERHEIDE, RH. Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 2018; 4(6):418–428.10.1016/j.trecan.2018.04.001602893529860986
Search in Google Scholar Back to article
4. LEWIS A., LI D., WILLIAMS J., SINGH, G. Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and Management. Oncology (Williston Park) 2017; 31(10):e1-e12.
Search in Google Scholar Back to article
5. HAEBERLE L., ESPOSITO I. Pathology of pancreatic cancer. Transl Gastroenterol Hepatol. 2019; 4(50):eCollection.10.21037/tgh.2019.06.02662434731304427
Search in Google Scholar Back to article
6. ABRAMSON MA., JAZAG A., VAN DER ZEE JA., WHANG EE. The molecular biology of pancreatic cancer. Gastrointest Cancer Res. 2007; 1(4):S7–S12.
Search in Google Scholar Back to article
7. EGAWA S., TOMA H., OHIGASHI H., OKUSAKA T., NAKAO A., HATORI T., et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 2012; 41(7):985–992.10.1097/MPA.0b013e318258055c22750974
Search in Google Scholar Back to article
8. PATRA KC., BARDEESY N., MIZUKAMAI Y. Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm. Clin Transl Gastroenterol. 2017; 8(4):e86.10.1038/ctg.2017.3541589928383565
Search in Google Scholar Back to article
9. MINO-KENUDSON M., FERNANDEZ-DEL CASTILLO C., BAB Y., VALSANGKAR NP., LISS AS., HSU M., et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011; 60(12):1712–1720.10.1136/gut.2010.232272380608521508421
Search in Google Scholar Back to article
10. TANAKA M., FERNANDEZ-DEL CASTILLO C., KAMISAWA T., JANG JY., LEVY P., OHTSUKA T., et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17(5):738–753.10.1016/j.pan.2017.07.00728735806
Search in Google Scholar Back to article
11. FISCHER CG., BELEVA GUTHRIE V., BRAXTON AM., ZHENG L., WANG P., SONG, Q. et al. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. Gastroenterology 2019; 157(4):1123–1137.10.1053/j.gastro.2019.06.001675695031175866
Search in Google Scholar Back to article
12. LEVINK I., BRUNO MJ., CAHEN DL. Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives. Curr Treat Options Gastroenterol. 2018; 16(3):316–332.10.1007/s11938-018-0190-2615357030196428
Search in Google Scholar Back to article
13. NAVEED S., QARI H., BANDAY T., ALTAF A., PARA M. Mucinous Cystic Neoplasms of Pancreas. Gastroenterology Res 2014; 7(2):44–50.10.14740/gr600e505107427785269
Search in Google Scholar Back to article
14. ZAMBONI G., SCARPA A., BOGINA G., IACONO C., BASSI C., TALAMINI G., SESSA F. et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999; 23(4):410–422.10.1097/00000478-199904000-00005
Search in Google Scholar Back to article
15. KOMMALAPATI A., TELLA SH., GOYAL G., MA WW., MAHIPAL, A. Contemporary Management of Localized Resectable Pancreatic Cancer. Cancers (Basel) 2018; 10(1):E24.10.3390/cancers10010024
Search in Google Scholar Back to article
16. BRAY F., FERLAY J., SOERJOMATARAM I., SIEGEL RL., TORRE L., JEMAL A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018; 68(6):394–424.10.3322/caac.21492
Search in Google Scholar Back to article
17. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Estimated number of deaths from 2018 to 2040, all cancers, both sexes, all ages. Accessed from <gco.iacr.fr/tomorrow>on 3/2/2020.
Search in Google Scholar Back to article
18. MIDHA S., CHAWLA S., GARG PK. Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Lett 2016; 381(1):269–277.10.1016/j.canlet.2016.07.022
Search in Google Scholar Back to article
19. RAIMONDI S., LOWENFELS AB., MORSELLI-LABATE AM., MAISONNEUVE P., PEZZILLI R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010; 24(3):349–358.10.1016/j.bpg.2010.02.007
Search in Google Scholar Back to article
20. WHITTEMORE AS., PAFFENBARGER RS. JR, ANDERSON K., HALPERN J. Early precursors of pancreatic cancer in college men. J Chronic Dis 1983; 36(3):251–256.10.1016/0021-9681(83)90059-0
Search in Google Scholar Back to article
21. TRANAH GH., HOLLEY EA., WANG F., BRACCI PM. Cigarette, cigar and pipe smoking, passive smoke exposure, and risk of pancreatic cancer: a population-based study in the San Francisco Bay Area. BMC Cancer 2011; 11:138.10.1186/1471-2407-11-138309432521496267
Search in Google Scholar Back to article
22. ZHENG J., GUINTER MA., MERCHANT AT., WIRTH MD., ZHANG J., STOLZENBERG-SOLOMON RZ. et al. Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr Rev. 2017; 75(11):883–908.10.1093/nutrit/nux038591445429025004
Search in Google Scholar Back to article
23. LI D. Diabetes and pancreatic cancer. Mol Carcinog. 2012; 51(1):64–74.10.1002/mc.20771323879622162232
Search in Google Scholar Back to article
24. SHARMA A., KANDLAKUNTA H., NAGPAL SJS., FENG Z., HOOS W., PETERSEN GM. et al. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Gastroenterol. 2018; 155(3):730–739.10.1053/j.gastro.2018.05.023612078529775599
Search in Google Scholar Back to article
25. KIRKEGARD J., CRONIN-FENTON D., HEIDE-JORGENSEN U., MORTENSEN FV. Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark. Gastroenterol. 2018; 154(6):1729–1736.10.1053/j.gastro.2018.02.01129432727
Search in Google Scholar Back to article
26. DOBBINS M., DECORBY K., CHOI BCK. The Association between Obesity and Cancer Risk: A Meta-Analysis of Observational Studies from 1985 to 2011. ISRN Prev Med. 2013;eCollection 2013.10.5402/2013/680536406285724977095
Search in Google Scholar Back to article
27. BERRINGTON DE GONZALEZ A., SWEETLAND S., SPENCER E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003; 89(3):519–523.10.1038/sj.bjc.6601140239438312888824
Search in Google Scholar Back to article
28. BEHRENS G., JOCHEM C., SCHMID D., KEIMLING M., RICCI C., LEITZMANN, MF. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2015; 30(4):279–298.10.1007/s10654-015-0014-925773752
Search in Google Scholar Back to article
29. BRACCI PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog. 2012; 51(1):53–63.10.1002/mc.20778334811722162231
Search in Google Scholar Back to article
30. YEO TP. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol. 2015; 42(1):8–18.10.1053/j.seminoncol.2014.12.00225726048
Search in Google Scholar Back to article
31. NAUDIN, S., VIALLON V., HASHIM D., FREISLING H., JENAB M., WEIDERPASS, E. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur J Epidemiol 2019;Epub ahead of print.10.1007/s10654-019-00559-6711613631564045
Search in Google Scholar Back to article
32. PETERSEN GM. Familial pancreatic cancer. Semin Oncol. 2916; 43(5):548–553.10.1053/j.seminoncol.2016.09.002523408527899186
Search in Google Scholar Back to article
33. AMUNDADOTTIR LT. Pancreatic Cancer Genetics. Int J Biol Sci. 2016; 12(3):314–325.10.7150/ijbs.15001475316026929738
Search in Google Scholar Back to article
34. SOURA E., ELIADES PJ., SHANNON K., STRATIGOS AJ., TSAO H. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016; 74(3):395–40.10.1016/j.jaad.2015.08.038476110526892650
Search in Google Scholar Back to article
35. KASTRINOS F., MUKHERJEE B., TAYOB N., WANG F., SPARR J., RAYMOND VM. et al. Risk of pancreatic cancer in families with Lynch syndrome. J Am Med Assoc. 2009; 302(16):1790–1795.10.1001/jama.2009.1529409162419861671
Search in Google Scholar Back to article
36. RUIJS MWG., VERHOEF S., ROOKUS MA., PRUNTEL R., VAN DER HOUT AH., HOGERVORST FBL. et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet. 2010; 47(6):421–428.10.1136/jmg.2009.07342920522432
Search in Google Scholar Back to article
37. GIARDIELLO FM., OFFERHAUS GJ., LEE DH., KRUSH AJ., BOOKER SV., KELLEY NC. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34(10):1394–1396.10.1136/gut.34.10.139413745488244108
Search in Google Scholar Back to article
38. THOMPSON D., DUEDAL A., KIRNER J., MCGUFFOG L., LAST J., REIMAN A. et al. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 2005; 97(11):813–822.10.1093/jnci/dji14115928302
Search in Google Scholar Back to article
39. BORECKA M., ZEMANKOVA P., VOCKA M., SOUCEK P., SOUKUPOVA J., KLEIBLOVA P. et al. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genet. 2016; 209(5):199–204.10.1016/j.cancergen.2016.03.00327106063
Search in Google Scholar Back to article
40. BRUNE KA., LAU B., PALMISANO E., CANTO M., GOGGINS MG., HRUBAN RH. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst 2010; 102(2):119–126.10.1093/jnci/djp466280834620068195
Search in Google Scholar Back to article
41. JACOBS EJ., CHANOCK SJ., FUCHS CS., LACROIX A., MCWILLIAMS RR., STEPLOWSKI E. et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 2010; 127(6):1421–1428.10.1002/ijc.25148292693920049842
Search in Google Scholar Back to article
42. SHIRTS BH., BURT RW., MULVIHILL SJ., CANNON-ALBRIGHT LA. A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol. 2010; 8(9):812–816.10.1016/j.cgh.2010.05.01220570637
Search in Google Scholar Back to article
43. WOLPIN BM., CHAN AT., HARTGE P., CHANOCK SJ., KRAFT P., HUNTER DJ. et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009; 101(6):424–431.10.1093/jnci/djp020265709519276450
Search in Google Scholar Back to article
44. HUANG BZ., STRAM DO., LE MARCHAND L., HAIMAN CA., WILKENS LR., PANDOL SL. Interethnic differences in pancreatic cancer incidence and risk factors: The Multiethnic Cohort. Cancer Med. 2019; 8(7):3592–360.10.1002/cam4.2209660157931066497
Search in Google Scholar Back to article
45. GOGGINS M., OVERBEEK KA., BRAND R., SYNGAL S., DEL CHIARO M., BARTSCH, DK. et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020; 69(1):7–17.10.1136/gutjnl-2019-319352729500531672839
Search in Google Scholar Back to article
46. STOFFEL EM., MCKERNIN SE., BRAND R., CANTO M., GOGGINS M., MORAVEK C. et al. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 2019; 37(2):153–164.10.1200/JCO.18.0148930457921
Search in Google Scholar Back to article
47. TEMPERO MA. NCCN Guidelines Updates: Pancreatic Cancer. J Natl Compr Canc Netw. 2019; 17(5.5):603–605.10.6004/jnccn.2018.004329784737
Search in Google Scholar Back to article
48. HENRIKSON NB., AIELLO BOWLES EJ., BLASI PR., MORRISON CC., NGUYEN M., PILLARISETTY VG. Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. J Amer Med Assoc. 2019; 322(5):445–454.10.1001/jama.2019.619031386140
Search in Google Scholar Back to article
49. JOERGENSEN MT., GERDES AM., SORENSEN J., SCHAFFALITZKY DE MUCKADELL O., MORTENSEN MB. Is screening for pancreatic cancer in high-risk groups cost-effective? – Experience from a Danish national screening program. Pancreatol. 2016; 16(4):584–592.10.1016/j.pan.2016.03.01327090585
Search in Google Scholar Back to article
50. CANTO MI., HRUBAN RH., FISHMAN EK., KAMEL IR., SCHULICK R., ZHANG Z. et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterol. 2012; 142(4):796–804.10.1053/j.gastro.2012.01.005332106822245846
Search in Google Scholar Back to article
51. YOSHIDA T., YAMASHITA Y., KITANO M. Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. Diagnostics (Basel) 2019; 9(3):E81.10.3390/diagnostics9030081678771031344904
Search in Google Scholar Back to article
52. HATA T., DAL MOLIN M., HONG SM., TAMURA K., SUENAGA M., YU J. et al. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers. Clin Cancer Res. 2017;23(14):3935–3944.10.1158/1078-0432.CCR-16-2244551155528148542
Search in Google Scholar Back to article
53. HART PA., TOPAZIAN M., RAIMONDO M., CRUZ-MONSERRATE Z., FISHER WE., LESINSKI GB. et al. Endoscopic Pancreas Fluid Collection: Methods and Relevance for Clinical Care and Translational Science. Am J Gastroenterol. 2016; 111(9):1258–1266.10.1038/ajg.2016.297556800327481304
Search in Google Scholar Back to article
54. SHIN EJ., TOPAZIAN M., GOGGINA MG., SYNGAL S., SALTZMAN JR., LEE JH. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc. 2015; 82(5):812–818.10.1016/j.gie.2015.02.028460923425930097
Search in Google Scholar Back to article
55. CAZACU IM., LUZURIAGA CHAVEZ AA., SAFTOIU A., VILMANN P., BHUTANI MS. A quarter century of EUS-FNA: Progress, milestones, and future directions. Endosc Ultrasound 2018; 7(3):141–160.10.4103/eus.eus_19_18603270529941723
Search in Google Scholar Back to article
56. KITANO M., YOSHIDA T., ITONAGA M., TAMURA T., HATAMARU K., YAMASHITA Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol. 2019; 54(1):19–32.10.1007/s00535-018-1519-2631498530406288
Search in Google Scholar Back to article
57. MCALLISTER F., MONTIEL MF., UBEROI GS., UBEROI AS., MAITRA A., BHUTANI MS. Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer. Gastroenterol Hepatol. 2017; 13(5):268–275.
Search in Google Scholar Back to article
58. TUMMALA P., JUNAIDI O., AGARWAL B. Imaging of pancreatic cancer: An overview. J Gastrointest Oncol. 2011; 2(3):168–174.
Search in Google Scholar Back to article
59. KANG HJ., LEE JM., JOO I., HUR BY., JEON JH., JANG JY. et al. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography. Radiol. 2016; 279(1):128–139.10.1148/radiol.201515021726517448
Search in Google Scholar Back to article
60. ZHANG L., SANAGAPALLI S., STOITA A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018; 24(19):2047–2060.10.3748/wjg.v24.i19.2047596081129785074
Search in Google Scholar Back to article
61. ASHIDA R., TANAKA S., YAMANAKA H., OKAGAKI S., NAKAO K., FUKUDA J. et al. The Role of Transabdominal Ultrasound in the Diagnosis of Early Stage Pancreatic Cancer: Review and Single-Center Experience. Diagnostics (Basel) 2018; 9(1):2.10.3390/diagnostics9010002646879730587766
Search in Google Scholar Back to article
62. CANTO MI., HARINCK F., HRUBAN RH., OFFERHAUS GJ., POLEY JW., KAMEL I. et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013; 62(3):339–347.10.1136/gutjnl-2012-303108358549223135763
Search in Google Scholar Back to article
63. PORUK KE., FIRPO MA., ADLER DG., MULVIHILL SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg. 2012; 257(1):17–26.10.1097/SLA.0b013e31825ffbfb
Search in Google Scholar Back to article
64. ELTA GH., ENESTVEDT BK., SAUER BG., LENNON AM. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018; 113(4):464–479.10.1038/ajg.2018.1429485131
Search in Google Scholar Back to article
65. KELLY FF., IHAB RK., JEANNE MH., HINA AT., MUSTAFA RB., VICTORIA C. et al. ACR Appropriateness Criteria: Pancreatic Cyst. Accessed from <https://acsearch.acr.org/docs/3127236/Narrative/> on 1/22/2020.
Search in Google Scholar Back to article
66. PORUK KE., GAY DZ., BROWN K., MULVIHILL JD., BOUCHER KM., SCAIFE CL. et al. The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013; 13(3):340–351.10.2174/1566524011313030003
Search in Google Scholar Back to article
67. MENG Q., SHI S., LIANG C., LIANG D., XU W., JI S. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017; 10:4591–4598.10.2147/OTT.S145708560808228979147
Search in Google Scholar Back to article
68. COSTACHE MI., COSTACHE CA., DUMITRESCU CI., TICA AA., POPESCU M., BALUTA EA. et al. Which is the Best Imaging Method in Pancreatic Adenocarcinoma Diagnosis and Staging – CT, MRI or EUS? Curr Health Sci J. 2017; 43(2):132–136.
Search in Google Scholar Back to article
69. TOFT J., HADDEN WJ., LAURENCE JM., LAM V., YUEN L., JANSSEN A. et al. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol. 2017; 92:17–23.10.1016/j.ejrad.2017.04.00928624015
Search in Google Scholar Back to article
70. ZHANG H., ZHU J., KE F., WENG M., WU X., LI M. et al. Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015; 2015:497942.10.1155/2015/497942456975826448940
Search in Google Scholar Back to article
71. SHRIKHANDE SV., BARRETO SG., GOEL M., ARYA S. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford) 2012; 14(10):658–668.10.1111/j.1477-2574.2012.00508.x346137122954001
Search in Google Scholar Back to article
72. JUDY MK., GANESH K., PRAVEEN KJ., PRASAD H., CHIDANANDA M., ARUN K. A Comparative Evaluation of USG and MRCP Findings in Biliary and Pancreatic Pathologies. Int J Contemp Med Res. 2017; 4(1):212–215.
Search in Google Scholar Back to article
73. MICHL P., PAULS S., GRESS TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006; 20(2):227–251.10.1016/j.bpg.2005.10.00516549326
Search in Google Scholar Back to article
74. ELOUBEIDI MA., VARADARAJULU S., DESAI S., SHIRLEY R., HESLIN MJ., MEHRA M. et al. A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer. J Gastrointest Surg. 2007; 11(7):813–819.10.1007/s11605-007-0151-x17440790
Search in Google Scholar Back to article
75. OKASHA HH., NAGA MI., ESMAT S., NAGUIB M., HASSANEIN M., HASSANI M. et al. Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Percutaneous Ultrasound-Guided Fine Needle Aspiration in Diagnosis of Focal Pancreatic Masses. Endosc Ultrasound 2014; 2(4):190–193.10.4103/2303-9027.121239
Search in Google Scholar Back to article
76. WANG XY., YANG F., JIN C., FU DL. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. World J Gastroenterol. 2014; 20(42):15580–15589.10.3748/wjg.v20.i42.15580422952225400441
Search in Google Scholar Back to article
77. BRONSTEIN YL., LOYER EM., KAUR H., CHOI H., DAVID C., DUBROW RA. et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004; 182(3):619–623.10.2214/ajr.182.3.182061914975959
Search in Google Scholar Back to article
78. LEGMANN P., VIGNAUX O., DOUSSET B., BARAZA AJ., PALAZZO L., DUMONTIER, I. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998; 170(5):1315–1322.10.2214/ajr.170.5.95746099574609
Search in Google Scholar Back to article
79. WONG JC., LU DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol. 2008; 6(12):1301–1308.10.1016/j.cgh.2008.09.01418948228
Search in Google Scholar Back to article
80. SHEN YN., BAI XL., LI GG., LIANG TB. Review of radiological classifications of pancreatic cancer with peripancreatic vessel invasion: are new grading criteria required? Cancer Imag. 2017; 17(1):14.10.1186/s40644-017-0115-7542008828477615
Search in Google Scholar Back to article
81. TANAKA S., KITAMRA T., YAMAMOTO K., FUJIKAWA S., IMAOKA T., NISHIKAWA S. et al. Evaluation of routine sonography for early detection of pancreatic cancer. Jpn J Clin Oncol. 1996; 26(6):422–427.10.1093/oxfordjournals.jjco.a0232599001347
Search in Google Scholar Back to article
82. MARINGHINI A., CIAMBRA M., RAIMONDO M., BACCELLIERE P., GRASSO R. DARDANONI G. Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. Pancreas 1993; 8(2):146–150.10.1097/00006676-199303000-000028460088
Search in Google Scholar Back to article
83. CONRAD C., FERNANDEZ-DEL CASTILLO C. Preoperative evaluation and management of the pancreatic head mass. J Surg Oncol. 2013; 107(1):23–32.10.1002/jso.2316522674403
Search in Google Scholar Back to article
84. GOONETILLEKE KS., SIRIWARDENA AK. Systematic review of carbohydrate antigen (CA 19–9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007; 33(3):266–270.10.1016/j.ejso.2006.10.00417097848
Search in Google Scholar Back to article
85. CHU LC., PARK S., KAWAMOTO S., WANG Y., ZHOU Y., SHEN W. Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience. J Am Coll Radiol. 2019; 16(9B):1338–1342.10.1016/j.jacr.2019.05.03431492412
Search in Google Scholar Back to article
86. CAZACU IM., UDRISTOUI A., GRUIONU LG., IACOB A., GRUIONU G., SAFTOIU A. Artificial intelligence in pancreatic cancer: Toward precision diagnosis. Endosc Ultrasound 2019; 8(6):357–359.10.4103/eus.eus_76_19692714531854344
Search in Google Scholar Back to article
87. OZKAN M., CAKIROGLU M., KOCAMAN O., KURT M., YILMAZ B., CAN G. et al. Age-based computer-aided diagnosis approach for pancreatic cancer on endoscopic ultrasound images. Endosc Ultrasound 2016; 5(2):101–107.10.4103/2303-9027.180473485078827080608
Search in Google Scholar Back to article
88. ZHU M., XU C., YU J., WU Y., LI C., ZHANG M. et al. Differentiation of pancreatic cancer and chronic pancreatitis using computer-aided diagnosis of endoscopic ultrasound (EUS) images: a diagnostic test. PLoS One 8 2013; 8(5):e63820.10.1371/journal.pone.0063820366038223704940
Search in Google Scholar Back to article
89. MUHAMMAD W., HART GR., NARTOWT B., FARRELL JJ., JOHUNG K., LIANG Y. et al. ancreatic Cancer Prediction Through an Artificial Neural Network. Front In Art Intel. 2019; 2(2):1–10.10.3389/frai.2019.00002
Search in Google Scholar Back to article
90. HASAN S., JACOB R., MANNE U., PALURI, R. Advances in pancreatic cancer biomarkers. Oncol Rev. 2019;13(1):410.10.4081/oncol.2019.410647800631044028
Search in Google Scholar Back to article
91. DUAN L., HU XQ., FENG DY., LEI SY., HU GH. GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer. Asian J Surg. 2013; 36(1):7–12.10.1016/j.asjsur.2012.08.00123270819
Search in Google Scholar Back to article
92. MELO SA., LUECKE LB., KAHLERT C., FERNANDEZ AF., GAMMON ST., KAYE J. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015; 523(7559):177–182.10.1038/nature14581482569826106858
Search in Google Scholar Back to article
93. LIU D., CHANG CH., GOLD DV., GOLDENBERG DM. Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer. Oncotarget 2015; 6(6):4274–4285.10.18632/oncotarget.2760441418925595893
Search in Google Scholar Back to article
94. DEBERNARDI S., MASSAT NJ., RADON TP., SANGARALINGAM A., BANISSI A., ENNIS DP. et al. Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Am J Cancer Res. 2015; 5(11):3455–3466.
Search in Google Scholar Back to article
95. CRISTIANO S., LEAL A., PHALLEN J., FIKSEL J., ADLEFF V., BRUHM DC. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 2019; 570(7761):385–389.10.1038/s41586-019-1272-6677425231142840
Search in Google Scholar Back to article
96. LAN B., ZENG S., GRUTZMANN R., PILARSKY C. The Role of Exosomes in Pancreatic Cancer. Int J Mol Sci. 2019; 20(18):E4332.10.3390/ijms20184332677078131487880
Search in Google Scholar Back to article

DOI: https://doi.org/10.2478/rjim-2020-0009 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 119 - 128

Submitted on: Feb 5, 2020

Published on: Aug 10, 2020

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

Related subjects:

Internal medicine, other,

Cardiology,

Gastroenterology,

Rheumatology

© 2020 Nathaniel E. Wiest, Varun P. Moktan, Sven P. Oman, Răzvan M. Chirilă, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 58 (2020): Issue 3 (September 2020)Next article